As of 2026-09-18, the Intrinsic Value of Sana Biotechnology Inc (SANA) is -3.81 USD. This SANA valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.10 USD, the upside of Sana Biotechnology Inc is -222.77%.
Based on its market price of 3.10 USD and our intrinsic valuation, Sana Biotechnology Inc (SANA) is overvalued by 222.77%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -3.81 - -3.81 | -3.81 | -222.77% |
| P/E | (20.63) - (22.27) | (20.93) | -775.2% |
| DDM - Stable | (5.17) - (20.69) | (12.93) | -517.0% |
| DDM - Multi | (5.24) - (17.19) | (8.14) | -362.5% |
| Market Cap (mil) | 862.70 |
| Beta | 3.88 |
| Outstanding shares (mil) | 278.29 |
| Enterprise Value (mil) | 805.63 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.81% |
| Cost of Debt | 5.00% |
| WACC | 7.24% |